Hexakit, Inc. is an Oklahoma-based biopharmaceutical company which is engaged in diagnostic drug development for cardiovascular diseases. Current research is focused on diagnosis of acute myocardial infarction (MI) by Positron Emission Tomography (PET)

Contact Us

Hexakit, Inc.
2401 Cheval Pointe Dr
Edmond, OK 73034

Email: info@hexakitbio.com